1.	Cytomegalovirus - Immunoprophylactic Adoptive Cellular Therapy Study Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CM-2008-01, 08/H0720/15, 74928896, NCT01077908
2.	Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: P010506, NCT01086735
3.	Phase II Randomized Study of Adoptive Transfer of Selected Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Patients at Risk of Cytomegalovirus Infection After Allogeneic Stem Cell Transplantation Phase: Phase II Type: Supportive care, Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: CRC-TU-ACE-CMV, CRCTU-ACE-CMV, 53325562, EU-20974, NCT00986557
4.	Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease Phase: Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 09-0744 / 201103095, NCT00871702